Media - Abzena


Antibody Engineering and Therapeutics

9 December 2019

The largest meeting bringing you the latest antibody science, technologies and partners needed to accelerate next[...] Read more

PEGS Europe Lisbon

18 November 2019

PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. In 2018, more than[...] Read more


Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids

Natural products have been used for many medicinal purposes for centuries. Antibody drug conjugates (ADCs) have utilized[...] Read more


Abzena announces successful technical transfer of Synaffix GlycoConnect™ Antibody Drug Conjugate (ADC) technology to enable use in client projects

San Diego, USA July 2019 – Abzena, the global partner research organization, announced it has successfully completed a[...] Read more

Abzena expands leadership team with Andrew Kraus as Chief Technology Officer and Philip Payne as Chief Commercial Officer

San Diego, USA , 21 June 2019 – Abzena, the leading global biologics and ADC target partner research organization,[...] Read more


We’re changing the way we brand our businesses

To provide our Partners with a single identity for the services and technologies offered across Antitope, PacificGMP,[...] Read more

Interested in our services? Get In Touch